SVEP1 couples adipose niche remodeling to macrophage activation and impaired metabolism in obesity

The extracellular matrix (ECM) of adipose tissue regulates metabolic homeostasis, yet how ECM composition drives adipose dysfunction in obesity remains only partially defined. Multi-omics profiling of visceral adipose tissue identified the multidomain ECM protein SVEP1 as a candidate regulator of adipose remodeling; SVEP1 was elevated in obese human adipose tissue and correlated with insulin resistance and systemic inflammation, and interaction analysis predicted associations with ECM proteins, integrins, and cytoskeletal regulators. On a chow diet, Svep1 heterozygous (Svep1+/-) mice gained less weight with lower fasting glucose, and their adipocytes showed enhanced lipolysis and AMPK activation. On a high-fat diet, Svep1+/- mice exhibited attenuated adiposity, improved glucose tolerance and insulin sensitivity, and fewer adipose macrophages with a shift away from a pro-inflammatory profile, alongside downregulation of inflammatory, lipid-metabolic, and ECM-remodeling pathways. Decellularized Svep1+/- matrix altered macrophage adhesion and phenotype relative to Svep1+/+ matrix, identifying SVEP1 as a matrix-borne mediator coupling adipose remodeling to immune activation and metabolic impairment. Together, these findings position the adipose ECM as an active driver of immunometabolic dysfunction and nominate SVEP1 and its receptor network as candidate targets in obesity.